BioCentury
ARTICLE | Product Development

Dealmaking and bispecifics cut trail to IPO for Y-Biologics

Korea Spotlight: Y-Biologics’ in-house antibody technology key to series of global partnerships 

August 19, 2021 9:58 PM UTC

The latest installment in a series of profiles of innovative South Korean companies. With seven disclosed oncology programs that include bispecifics and partners in the East and West, Y-Biologics is ...



Access this Article